Results of Preoperative Hepatic Arterial Infusion Chemotherapy in Patients Undergoing Liver Resection for Colorectal Liver Metastases

[1]  C. Pulitano,et al.  A risk score for predicting perioperative blood transfusion in liver surgery , 2007, The British journal of surgery.

[2]  M. Ychou,et al.  Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. , 2006, European journal of cancer.

[3]  C. Pulitano,et al.  “Technological” approach versus clamp crushing technique for hepatic parenchymal transection: A comparative study , 2006, Journal of Gastrointestinal Surgery.

[4]  C. Pulitano,et al.  Impact of preoperative steroids administration on ischemia‐reperfusion injury and systemic responses in liver surgery: A prospective randomized study , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[5]  N. Kemeny,et al.  Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  B. Nordlinger,et al.  Influence of Preoperative Chemotherapy on the Risk of Major Hepatectomy for Colorectal Liver Metastases , 2006, Annals of surgery.

[7]  S. Curley,et al.  Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  L. Schwartz,et al.  Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Agnès Laplanche,et al.  Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  W. Hawkins,et al.  Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. , 2005, Journal of the American College of Surgeons.

[11]  N. Kemeny,et al.  Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  I. Endo,et al.  Effectiveness of prehepatectomy intra-arterial chemotherapy for multiple bilobar colorectal cancer metastases to the liver: a clinicopathologic study of peritumoral vasculobiliary invasion. , 2005, Surgery.

[13]  F. Lévi,et al.  Tumor Progression While on Chemotherapy: A Contraindication to Liver Resection for Multiple Colorectal Metastases? , 2004, Annals of surgery.

[14]  Bernard Paule,et al.  Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy: A Model to Predict Long-term Survival , 2004, Annals of surgery.

[15]  M. Salvioni,et al.  Complications after percutaneous transaxillary implantation of a catheter for intraarterial chemotherapy of liver tumors: clinical relevance and management in 204 patients. , 2004, AJR. American journal of roentgenology.

[16]  R. Golfieri,et al.  [Combined treatment of inoperable liver metastases from colorectal cancer]. , 2003, Tumori.

[17]  A. Chang,et al.  Hepatic artery chemotherapy for colorectal liver metastases: technical considerations and review of clinical trials. , 2002, Surgical oncology.

[18]  M. Morse,et al.  Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy , 2002 .

[19]  M. Salvioni,et al.  Percutaneous vs. surgical placement of hepatic artery indwelling catheters for regional chemotherapy. , 2002, Hepato-gastroenterology.

[20]  L. Schwartz,et al.  Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  L H Blumgart,et al.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.

[22]  M. Kornmann,et al.  Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases. , 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[23]  M. Ducreux,et al.  Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. , 1995, Journal of the American College of Surgeons.

[24]  A. Altendorf-Hofmann,et al.  Factors influencing the natural history of colorectal liver metastases , 1994, The Lancet.

[25]  J. Wille,et al.  Pressure sores and pressure-decreasing mattresses: controlled clinical trial , 1994, The Lancet.

[26]  N. Kemeny,et al.  A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer , 1992, Cancer.

[27]  W J Martone,et al.  National nosocomial infections surveillance system (NNIS): description of surveillance methods. , 1991, American journal of infection control.

[28]  A. Altendorf-Hofmann,et al.  Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history , 1990, The British journal of surgery.

[29]  J M Collins,et al.  Pharmacologic rationale for regional drug delivery. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  E. Watkins,et al.  CHEMOTHERAPY OF METASTATIC LIVER CANCER BY PROLONGED HEPATIC-ARTERY INFUSION. , 1964, The New England journal of medicine.

[31]  F. Lévi,et al.  Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  L. Ellis,et al.  Surgery After Downstaging of Unresectable Hepatic Tumors With Intra-Arterial Chemotherapy , 2000, Annals of Surgical Oncology.

[33]  M. Makuuchi,et al.  The Brisbane 2000 terminology of liver anatomy and resections. , 2000 .